Wiskott-Aldrich syndrome

Treatment of Wiskott-Aldrich syndrome is currently based on correcting symptoms.

In Wiskott-Aldrich syndrome, the platelets are small and do not function properly.

Some research suggests that transfer factor taken from humans might extend life in people with Wiskott-Aldrich syndrome.

Studies of correcting Wiskott-Aldrich syndrome with gene therapy using a lentivirus have begun.

Transfer factor therapy in the Wiskott-Aldrich syndrome.

A genetic disease called Wiskott-Aldrich syndrome.

Defects in the CD43 molecule are associated with the development of Wiskott-Aldrich syndrome.

ITSN2 has been shown to interact with Wiskott-Aldrich syndrome protein.

Having one of the following medical conditions: An inherited immune disorder (for example, hypogammaglobulinemia or Wiskott-Aldrich syndrome).

A defect in CD43 molecule has been found in patients with Wiskott-Aldrich syndrome.

Proof-of-principle for successful hematopoietic stem cell gene therapy has been provided for patients with Wiskott-Aldrich syndrome.

Decreased levels of Wiskott-Aldrich syndrome protein and/or confirmation of a causative mutation provides the most definitive diagnosis.

(Wasp Homology Domain 2 - the name is derived from Wiskott-Aldrich syndrome protein).

Wiskott-Aldrich syndrome protein (Biology)

Patients who suffer from Wiskott-Aldrich Syndrome demonstrate, through their immune cells, continued evidence of the role podosomes fulfill in cell motility.

Wiskott-Aldrich syndrome (WAS)

These disorders include Wiskott-Aldrich syndrome, X-linked thrombocytopenia and X-linked congenital neutropenia.

Rare examples are Bernard-Soulier syndrome, Wiskott-Aldrich syndrome and Glanzmann's thrombasthenia.

Wiskott-Aldrich syndrome (WAS) patients also present with eczema, autoimmune manifestations, recurrent bacterial infections and lymphoma.

Wiskott-Aldrich syndrome protein family member 2 is a protein that in humans is encoded by the WASF2 gene.

The charity is named after Anthony Nolan (born 1971, died 1979), who did not suffer from leukaemia but from Wiskott-Aldrich syndrome, a rare inherited blood disorder.

This domain was first recognized as an essential element for the regulation of the cytoskeleton by the mammalian Wiskott-Aldrich syndrome protein (WASP) family.

Other immune problems range from severe immune deficiencies of childhood such as Wiskott-Aldrich syndrome to less severe deficiencies such as common variable immunodeficiency.

A variety of immune deficiencies present at birth such as ataxia-telangectasia, Wiskott-Aldrich syndrome, common variable immunodeficiency, severe combined immunodeficiency, and X-linked lymphoproliferative syndrome.

The Wiskott-Aldrich Syndrome Protein (WASp) is a 502-amino acid protein that is expressed in cells of the hematopoietic system.